Showing results (31-40 of 181) with videos related to

Sort By:
Pageof 19
Journal of Drug Targeting|April 21, 2020
Current status and applications of animal models in pre-clinical development of orally administered insulin-loaded nanoparticlesChun Y Wong, Hani Al-Salami, Crispin R Dass
Artificial Cells, Nanomedicine, and Biotechnology|July 12, 2014
Characterization of a novel bile acid-based delivery platform for microencapsulated pancreatic β-cellsArmin Mooranian, Rebecca Negrulj, Frank Arfuso, et al.
Drug Delivery|November 27, 2015
A comprehensive study of novel microcapsules incorporating gliclazide and a permeation enhancing bile acid: hypoglycemic effect in an animal model of Type-1 diabetesSangeetha Mathavan, Nigel Chen-Tan, Frank Arfuso, et al.
Therapeutic Delivery|March 2, 2023
Applications of bile acids as biomaterials-based modulators, in biomedical science and microfluidicsWee Ling Koh, Thomas Foster, Armin Mooranian, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|May 23, 2017
Diabetes development increased concentrations of the conjugated bile acid, taurocholic acid in serum, while treatment with microencapsulated-taurocholic acid exerted no hypoglycaemic effectsSangeetha Mathavan, Momir Mikov, Svetlana Golocorbin-Kon, et al.
Artificial Cells, Nanomedicine, and Biotechnology|July 28, 2015
The role of the bile acid chenodeoxycholic acid in the targeted oral delivery of the anti-diabetic drug gliclazide, and its applications in type 1 diabetesSangeetha Mathavan, Nigel Chen-Tan, Frank Arfuso, et al.
Pharmaceutics|August 26, 2023
The Impact of Pigment-Epithelium-Derived Factor on MCF-7 Cell Metabolism in the Context of Glycaemic ConditionRaziyeh Abooshahab, Kourosh Hooshmand, Hani-Al Salami, et al.
AAPS Pharmscitech|August 1, 2018
Morphological, Stability, and Hypoglycemic Effects of New Gliclazide-Bile Acid Microcapsules for Type 1 Diabetes Treatment: the Microencapsulation of Anti-diabetics Using a Microcapsule-Stabilizing Bile AcidSangeetha Mathavan, Nigel Chen-Tan, Frank Arfuso, et al.
The Journal of Pharmacy and Pharmacology|December 2, 2017
Oral insulin delivery: existing barriers and current counter-strategiesAhmed Gedawy, Jorge Martinez, Hani Al-Salami, et al.
The Journal of Pharmacy and Pharmacology|March 26, 2021
β-Cyclodextrin-containing chitosan-oligonucleotide nanoparticles improve insulin bioactivity, gut cellular permeation and glucose consumptionChun Yuen Jerry Wong, Hani Al-Salami, Crispin R Dass
Pageof 19